"Study Finds Lower Suicidal Ideation Risk in Users of Diabetes, Weight Loss Drugs Ozempic and Wegovy"
TL;DR Summary
A study funded by the NIH has found that semaglutide, a medication used to treat obesity and type 2 diabetes, is associated with a significantly lower risk of suicidal ideation compared to other treatments. The research, which analyzed electronic health records, showed a 49% to 73% lower risk for patients treated with semaglutide. These findings counter anecdotal reports suggesting a potential increase in suicidal thoughts among users of the drug. The study emphasizes the need for further investigation into the long-term effects of semaglutide on mental health and suicide attempts.
Topics:business##health-and-medicine#mentalhealth#obesity#semaglutide#suicidalideation#type2diabetes
- Semaglutide associated with lower risk of suicidal ideations compared to other treatments prescribed for obesity or type 2 diabetes National Institutes of Health (.gov)
- FDA looking into reports of hair loss, suicidal thoughts in people using popular drugs for diabetes and weight loss WLWT Cincinnati
- Weight loss drug warning FOX 26 Houston
- Ozempic, Wegovy not associated with higher risk of suicidal ideation in large review of US health records CNN
- Ozempic and Wegovy Users Had Less Risk of Suicidal Thoughts in Large Study The New York Times
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
4 min
vs 4 min read
Condensed
89%
794 → 90 words
Want the full story? Read the original article
Read on National Institutes of Health (.gov)